Dr. Sneha Ramakrishna, MD
Claim this profileStanford University
Area of expertise
Osteosarcoma
Sneha Ramakrishna, MD has run 2 trials for Osteosarcoma. Some of their research focus areas include:
Neuroblastoma
Sneha Ramakrishna, MD has run 2 trials for Neuroblastoma. Some of their research focus areas include:
Affiliated Hospitals
Stanford University
Lucile Packard Children's Hospital (LPCH)
Clinical Trials Sneha Ramakrishna, MD is currently running
CAR T-Cell Therapy
for Brain Cancer
This is an open label, non-randomized, single site Phase I study to test the manufacturing feasibility and safety of locoregional (LR) administration of B7-H3CART into the central nervous system of adult subjects with recurrent IDH wild-type GBM using a standard 3+3 dose escalation design.
Recruiting
1 award
Phase 1
B7-H3CART
for Solid Tumors
The purpose of this study is to test the manufacturing feasibility and safety of intravenous (IV) administration of B7-H3CART in children and young adult subjects with relapsed and/or refractory solid tumors expressing B7-H3 target using a standard 3+3 dose escalation design.
Recruiting
1 award
Phase 1
3 criteria
More about Sneha Ramakrishna, MD
Clinical Trial Related
3 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 4 Active Clinical Trials
Treatments Sneha Ramakrishna, MD has experience with
- B7-H3CART
- Afamitresgene Autoleucel
- Cyclophosphamide
- Fludarabine
- GD2 CAR T Cells
Breakdown of trials Sneha Ramakrishna, MD has run
Soft Tissue Sarcoma
Sarcoma
Peripheral Nerve Sheath Tumor
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Sneha Ramakrishna, MD specialize in?
Sneha Ramakrishna, MD focuses on Osteosarcoma and Neuroblastoma. In particular, much of their work with Osteosarcoma has involved Stage IV patients, or patients who are HLA-A positive.
Is Sneha Ramakrishna, MD currently recruiting for clinical trials?
Yes, Sneha Ramakrishna, MD is currently recruiting for 4 clinical trials in Palo Alto California. If you're interested in participating, you should apply.
Are there any treatments that Sneha Ramakrishna, MD has studied deeply?
Yes, Sneha Ramakrishna, MD has studied treatments such as B7-H3CART, Afamitresgene autoleucel, Cyclophosphamide.
What is the best way to schedule an appointment with Sneha Ramakrishna, MD?
Apply for one of the trials that Sneha Ramakrishna, MD is conducting.
What is the office address of Sneha Ramakrishna, MD?
The office of Sneha Ramakrishna, MD is located at: Stanford University, Palo Alto, California 94305 United States. This is the address for their practice at the Stanford University.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.